Summary of methylation data. by Linda Sterrenburg (194954)

“…<p>Panel summarizing methylation of the <i>Crf</i> gene at sites in 5′ flanking region, exon 1, intron and exon 2 of <i>Crf,</i> in the PVN, BST and CeA. …”

Median Expression and DEXP Values for Different Developmental Stages of Root and Flower by Igor V Tetko (7846)

“…The differences in DEXP values of S/MAR+ and S/MAR− genes decrease with the increasing age of the tissues. The 5% confidence intervals for all values are shown.…”

Endogenously expressed TSPX enhances HBx degradation in 293T cells. by Tatsuo Kido (211707)

“…Forty-eight hours after transfection, cells were lysed and analyzed by Western-blot using anti-V5 and anti-HA antibodies. Treatment with TSPX siRNA resulted in significant increase in HA-HBx expression (2.8 fold). …”

Drug Absorption Efficiency in <em>Caenorhbditis elegans</em> Delivered by Different Methods by Shan-Qing Zheng (382120)

“…The concentration of resveratrol and FUDR increased gradually within <i>C. elegans</i> and reached the highest during 12 hours to one day and then decreased slowly. At the same time point, the higher the drug concentration, the higher the metabolism rate. …”

Figure 4. Transcriptional effects of SOX15 perturbation. by Merrick Pierson Smela (7036586)

The burden of ischemic heart disease and the epidemiologic transition in the Eastern Mediterranean Region: 1990-2019 by Sadeghi, Masoumeh

“…The age-standardized prevalence of IHD in the EMR increased from 5.0% to 5.5% between 1990 and 2019, while it decreased at the global level. …”
Get full text
Get full text

Influence of the incorporation of flexographic photopolymer plate residues on the mechanical properties of epoxy by Aline Ferretto (15297675)

“…Both residual particles were incorporated into the epoxy at concentrations of 2.5, 5 and 7.5 wt%. The main results indicate that PP was not efficient as a modifier of the epoxy system. …”

TAT-labeled dysferlin-peptides reduce the expression of the ER stress sensor BiP. by Verena Schoewel (118330)

“…<p>(<b>A</b>) In <i>DYSF</i> p.G299R human myotubes <i>HSPA5</i> gene expression is significantly up-regulated. …”

Supplementary Figure 4 from Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome... by Prahalathan Pichavaram (18287684)

Effects of barrier distances mediated by topoisomerase binding. by Boaz Goldberg (22601119)

“…We plot the log2 fold change in the expression rate in response to (A) reducing the barrier distances from 10 kb to 1 kb, (B) reducing nonspecific topoisomerase activities 10-fold, (C) reducing the barrier distances from 10 kb to 1 kb and increasing topoisomerase nonspecific activities 10-fold to compensate, (D) increasing the barrier distances from 10 kb to 100 kb, (E) increasing the nonspecific topoisomerase activities 10-fold, and (F) increasing the barrier distances from 10 kb to 100 kb and decreasing the nonspecific topoisomerase activities 10-fold to compensate. …”

The effects of growth status on the pattern of cytosine methylation. by Selcen Çelik (547618)

“…Scale bar = 10 µm <b>E</b> The decrease in the staining levels of 5meC in MEFs after treatment with 5 µM 5-aza-2′-deoxycytidine-2′-deoxycytidine compared to control cells (Untreated) as detected by fluorescence activated flow cytometry (p<0.05). 5meC is tagged with a PerCP-conjugated antibody and detected at fluorescence channel-3. * p<0.05.…”

Image_1_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Table_3_Global burden of lower respiratory infections during the last three decades.DOC by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Presentation_2_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Image_11_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Image_14_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Image_9_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Table_2_Global burden of lower respiratory infections during the last three decades.DOC by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Image_8_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”

Table_1_Global burden of lower respiratory infections during the last three decades.DOCX by Saeid Safiri (3713035)

“…The global age-standardized incidence and death rates for LRIs were 6,295 (5,887.4–6,737.3) and 34.3 (31.1–37.9) per 100,000 in 2019, which represents a 23.9% (22.5–25.4) and 48.5% (42.9–54.0) decrease, respectively since 1990. …”